BPC-157 is being investigated for its applications in tissue regeneration, treatment of inflammatory bowel disease, and other cellular processes that support longevity in animals [2, 3]
(1) This unique formulation consists of approximately 25% peptide fragments and 75% amino acids, with molecular weights below 10,000 daltons, enabling the compound to cross the blood-brain barrier and potentially exert direct effects on central nervous system tissue
Mitochondrial Therapy Recently, there has been a growing interest in mitochondrial therapy, especially in the form of artificial mitochondrial transfer/transplant (AMT/T) or the use of mitochondria as a Living Drug
The neurobiology of acetyl-L-carnitine 10
The first 4 to 8 weeks after starting semaglutide or tirzepatide are the adjustment period
Unique molecular signatures of Alzheimers disease amyloid peptide mutations and deletion during aggregate/oligomer/fibril formation